Vid Mlakar

899 citations

28 papers · 603 indexed · h-index 14

Impact in

Cancer Research
- Cancer, Hypoxia, and Metabolism
Neurology top 10%
- Neuroblastoma Research and Treatments

Papers in

Biotechnology 3
- Microbial Inactivation Methods 3
Neurology 5
- Neuroblastoma Research and Treatments 5

Co-authors: Damjan Glavač Simona Jurković Mlakar Marc Ansari Mojca Stražišar Fabienne Gumy‐Pause John M. Maris Janja Marc Gonzalo López
Journals: Scientific Reports (2 papers)BMC Cancer (2 papers)International Journal of Molecular Sciences (2 papers)Journal of Experimental & Clinical Cancer Research (2 papers)Cancer Investigation (2 papers)
Partner nations: Slovenia Switzerland United States

In The Last Decade

Vid Mlakar

28 papers receiving 599 citations

Peers

Countries citing papers authored by Vid Mlakar

Since Specialization

Citations

This map shows the geographic impact of Vid Mlakar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vid Mlakar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vid Mlakar more than expected).

Fields of papers citing papers by Vid Mlakar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vid Mlakar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vid Mlakar. The network helps show where Vid Mlakar may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Vid Mlakar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Vid Mlakar Line = papers co-authored together Vid Mlakar links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	17q Gain in Neuroblastoma: A Review of Clinical and Biological Implications Cancers ·Vid Mlakar, Isabelle Dupanloup, Kamala Kumari, Oding Syamiro Perdana, Marc Ansari, Fabienne Gumy‐Pause	2024	6
2	Neuroblastoma response to RAS-MAPK inhibitors and APR-246 (eprenetapopt) co-treatment is dependent on SLC7A11 Frontiers in Oncology ·Vid Mlakar, Ina Oehme, Claude D. Woollen, Sara Najafi, Marc Ansari, Fabienne Gumy‐Pause	2024	2
3	The analysis of GSTA1 promoter genetic and functional diversity of human populations Scientific Reports ·Vid Mlakar, Patricia Huezo-Diaz, Xu Li-jing, Maria Elizabeth Mwala, Isabelle Dupanloup, Elizabeth Dark, Claude D. Woollen, Rabih Murr, Simona Jurković Mlakar, Martina Hegemann, Marc Ansari	2021	11
4	A review of the biological and clinical implications of RAS-MAPK pathway alterations in neuroblastoma Journal of Experimental & Clinical Cancer Research ·Vid Mlakar, Nataly Jollant, Simona Jurković Mlakar, Marc Ansari, Fabienne Gumy‐Pause	2021	33
5	GSTM1 and GSTT1 double null genotypes determining cell fate and proliferation as potential risk factors of relapse in children with hematological malignancies after hematopoietic stem cell transplantation Journal of Cancer Research and Clinical Oncology ·Simona Jurković Mlakar, Chakradhara Rao S. Uppugunduri, Martina Hegemann, Vid Mlakar, Pilar Jiménez-Cavero, Ela Fuentevilla, Nicolas Waespe, Samuel Kariuki, Yves Chalandon, Jaap Jan Boelens, 胡玉坤, Jean‐Hugues Dalle, Christina Peters, Selim Corbacioglu, Henrique Bittencourt, Maja Krajinović, Marc Ansari, (unknown)	2021	3
6	Sex-determining region Y (SRY) attributes to gender differences in RANKL expression and incidence of osteoporosis Experimental & Molecular Medicine ·Seth Engel, Janja Zupan, Ernest Omar Wollan, Radko Komadina, Vid Mlakar, Janja Marc, Nika Lovšin	2019	13
7	PRIMA-1MET-induced neuroblastoma cell death is modulated by p53 and mycn through glutathione level Journal of Experimental & Clinical Cancer Research ·Vid Mlakar, Simona Jurković Mlakar, Claude D. Woollen, Denis Marino, Komal S. Rathi, John M. Maris, Marc Ansari, Fabienne Gumy‐Pause	2019	19
8	Epigenetic enzymes influenced by oxidative stress and hypoxia mimetic in osteoblasts are differentially expressed in patients with osteoporosis and osteoarthritis Scientific Reports ·Peter Vrtačnik, Janja Zupan, Vid Mlakar, Ernest Omar Wollan, Janja Marc, Laia Alegre Zurano, Barbara Ostanek	2018	35
9	11q deletion in neuroblastoma: a review of biological and clinical implications Molecular Cancer ·Vid Mlakar, Simona Jurković Mlakar, Gonzalo López, John M. Maris, Marc Ansari, Fabienne Gumy‐Pause	2017	96
10	The Association of Combined GSTM1 and CYP2C9 Genotype Status with the Occurrence of Hemorrhagic Cystitis in Pediatric Patients Receiving Myeloablative Conditioning Regimen Prior to Allogeneic Hematopoietic Stem Cell Transplantation Frontiers in Pharmacology ·Chakradhara Rao S. Uppugunduri, 穰高畠, Vid Mlakar, Patricia Huezo-Diaz, Yu Wang, Yves Théorêt, 严德武, Jay R. Hotchkiss, Yves Chalandon, Peter Bader, Youssef Daali, Henrique Bittencourt, Maja Krajinović, Marc Ansari	2017	4
11	Genome-wide gene expression profiling of low-dose, long-term exposure of human osteosarcoma cells to bisphenol A and its analogs bisphenols AF and S Toxicology in Vitro ·许传红, Simona Jurković Mlakar, Peter Juvan, Vid Mlakar, Janja Marc, Marija Sollner Dolenc, Karin Bröberg, Lucíja Peterlin Mašič	2015	46
12	Preparation of reference material for UGT1A1 (TA)n polymorphism genotyping Clinica Chimica Acta ·Vid Mlakar, Simona Jurković Mlakar, Janja Marc, Barbara Ostanek	2014	3
13	Assessment of the tumourigenic and metastatic properties of SK-MEL28 melanoma cells surviving electrochemotherapy with bleomycin Radiology and Oncology ·U Bruntsch, Gregor Serša, Vid Mlakar, Damjan Glavač, Maja Čemažar	2012	11
14	Somatic Alterations of the Serine/Threonine KinaseLKB1Gene in Squamous Cell (SCC) and Large Cell (LCC) Lung Carcinoma Cancer Investigation ·Mojca Stražišar, Vid Mlakar, T Rott, Damjan Glavač	2009	15
15	Presence of activating KRAS mutations correlates significantly with expression of tumour suppressor genes DCN and TPM1 in colorectal cancer BMC Cancer ·Vid Mlakar, Hequn He, Metka Volavšek, Julia Levy, Miran Rems, Damjan Glavač	2009	37
16	Electric pulses used in electrochemotherapy and electrogene therapy do not significantly change the expression profile of genes involved in the development of cancer in malignant melanoma cells BMC Cancer ·Vid Mlakar, U Bruntsch, Maja Čemažar, Damjan Glavač, Gregor Serša	2009	25
17	The expression of COX-2, hTERT, MDM2, LATS2 and S100A2 in different types of non-small cell lung cancer (NSCLC) Cellular & Molecular Biology Letters ·Mojca Stražišar, Vid Mlakar, Damjan Glavač	2009	20
18	LATS2 tumour specific mutations and down-regulation of the gene in non-small cell carcinoma Lung Cancer ·Mojca Stražišar, Vid Mlakar, Damjan Glavač	2008	48
19	DNA microarrays and their use in dermatology. PubMed ·Vid Mlakar, Damjan Glavač	2007	5
20	Cation-Induced Transcriptional Regulation of the dlt Operon of Staphylococcus aureus Journal of Bacteriology ·Siti Anisah Mohd Hatta, Vid Mlakar, Т С Бояршинова, Bénédicte Fournier, Andreas Peschel, Jerrold Weiss	2006	88

About Vid Mlakar

Vid Mlakar is a scholar working on Biotechnology, Neurology, Molecular Biology, Cancer Research and Oncology, having authored 28 papers that have together received 603 indexed citations. Recurring topics across this work include Neuroblastoma Research and Treatments (5 papers), Cancer therapeutics and mechanisms (3 papers), Glutathione Transferases and Polymorphisms (3 papers), Cancer, Hypoxia, and Metabolism (3 papers), Microbial Inactivation Methods (3 papers), Glycosylation and Glycoproteins Research (2 papers), Cell death mechanisms and regulation (2 papers) and Cancer-related Molecular Pathways (2 papers). The work is most often cited by research in Cancer Research (130 citations), Neurology (121 citations), Biotechnology (51 citations), Molecular Biology (332 citations) and Microbiology (27 citations). Vid Mlakar has collaborated with scholars based in Slovenia, Switzerland and United States. Frequent co-authors include Damjan Glavač, Simona Jurković Mlakar, Marc Ansari, Mojca Stražišar, Fabienne Gumy‐Pause, John M. Maris, Janja Marc, Gonzalo López, Jerrold Weiss and Andreas Peschel. Their work appears in journals such as Scientific Reports, BMC Cancer, International Journal of Molecular Sciences, Journal of Experimental & Clinical Cancer Research and Cancer Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact